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Abstract
Background: Several studies have examined tracking pattern of blood lipids level during long follow-up periods in
Western countries. However, there have been few such studies in Asian populations.
Methods: The Kangwha Study is a community-based prospective cohort study that started in 1986 on Kangwha
Island, South Korea. A total of 432 participants (47% men) were enrolled in the study, during which serum total
cholesterol, triglycerides, and high-density lipoprotein (HDL) cholesterol levels were measured for each participant
at least once during adolescence (12–16 years of age) and again at least once during adulthood (25–35 years of
age). The tracking patterns of the blood lipid levels were determined using Spearman correlation coefficients and
tracking coefficients from generalized estimating equations.
Results: The Spearman correlation coefficients between lipid measurements ranged from 0.12 to 0.73 depending
on the lipid profile and measurement time interval; all were significant (p < 0.05). The magnitude of the coefficients
tended to decrease as the time interval increased. When adjusted for age, sex, body mass index, and blood
pressure, the tracking coefficients were 0.58 (95% confidence interval [CI]: 0.54–0.63) for total cholesterol, 0.39
(95% CI: 0.31–0.48) for triglycerides, and 0.51 (95% CI: 0.47–0.56) for HDL cholesterol. In a subgroup analysis by sex,
the tracking coefficients were higher for women than for men, except for HDL cholesterol.
Conclusions: The tracking patterns of blood lipids from adolescence to adulthood were notable. This study
supports the importance of measuring lipids during adolescence for identifying high-risk individuals.
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Background
Atherosclerotic cardiovascular disease (CVD) begins in
the early periods of life, and childhood metabolic abnor-
malities may continue through later life [1–3]. Several
longitudinal studies have demonstrated tracking patterns
for CVD risk factors over a long-term period [4–7]. By
definition, tracking patterns mean the correlation be-
tween early and later measurements over the lifetime
with respect to a certain variable [8]. The existence of a
tracking pattern for CVD risk factors indicates that the
timely detection of CVD risk factors in early life may
make it possible to predict adult CVD.
Dyslipidemia (an abnormal blood lipid profile level) is
an established risk factor for CVD and premature death
[9–11]. Several long-term studies have evaluated the
tracking patterns of lipids in Western countries [3, 12, 13].
However, there is an ethnic disparity in the prevalence of
dyslipidemia and lipid levels [14], and longitudinal data is
lacking for Asian populations [15]. To our knowledge, a
few longitudinal studies have evaluated the tracking pat-
terns of lipids in Asian populations, but these studies had
relatively short follow-up periods [16, 17].
Our study aims to evaluate the tracking patterns of blood
lipid levels from adolescence to adulthood. Specifically, we
wanted to demonstrate the tracking patterns for total
cholesterol, triglycerides, high-density lipoprotein (HDL)
cholesterol, non-HDL cholesterol, and low-density lipopro-
tein (LDL) cholesterol. We also assessed the magnitude of
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tracking coefficients for these lipids. Furthermore, the
tracking patterns were evaluated according to sex and
measurement time intervals.
Methods
Study participants
The Kangwha study is a community-based prospective co-
hort study that started in 1986 with 430 children on Kang-
wha Island, Korea [16, 18]. At the time, the participants in
the Kangwha study were first-grade students in local
elementary schools; most of them were 6 years old. An-
nual examinations were conducted during each partici-
pant’s childhood and adolescence (1987–1997). The
number of participants was expanded several times to in-
clude other students who lived on Kangwha Island and
were in the same grade as the participants during the
same period. After these expansions, four follow-up stud-
ies were conducted when the participants were adults:
adult wave 1 in 1999–2001, adult wave 2 in 2005, adult
wave 3 in 2010–2011, and adult wave 4 in 2014–2016.
Lipid profiles were measured three times during adoles-
cence: adolescence 1 in 1992, adolescence 2 in 1994, and
adolescence 3 in 1996. A total of 896 participants were tested
at least once during this period. In this study, we enrolled
the 432 participants who had their lipid profiles measured at
least once during adult waves 2–4. Each participant in our
study had at least two (and up to six) lipid measurements.
This study does not use the data from adult wave 1 because
the participants were in a transition stage from adolescence
to adulthood at that time. Informed consent was obtained
from all participants in our study. The study protocol was
approved by the institutional review board of Severance
Hospital at Yonsei University Health System (4–2014-0914).
Measurements
Standing height and weight were measured to 0.1 cm and
0.1 kg, respectively, for each study participant. Body mass
index (BMI) was calculated by dividing weight (kg) by the
square of the height (m2). Resting systolic blood pressure
(SBP) and diastolic blood pressure (DBP) were measured
from the right brachial artery by trained researchers. Lipid
measurements were performed using blood samples after
overnight fasting. Total cholesterol, triglycerides, and
HDL cholesterol were measured using enzymatic
methods: in adolescence, the Hitachi 747 (Hitachi, Japan);
in adult wave 2, the Hitachi 7150 (Hitachi, Japan); in year
1 of adult wave 3, the ADVIA 1650 (Siemens, Princeton,
NJ, USA); and in year 2 of adult wave 3 and adult wave 4,
the ADVIA 1800 (Siemens, Princeton, NJ, USA). Non-
HDL cholesterol was calculated by subtracting the HDL
cholesterol level from the total cholesterol level. LDL
cholesterol was calculated using the Friedewald formula
when blood triglycerides were <4.52 mmol/L [19].
Statistical analysis
The general characteristics of study participants are pre-
sented as means and standard deviations (SD) or numbers
and percentages. Because not all study participants partici-
pated in all measurements, the number of participants
may vary depending on the measurement year. To com-
pare the differences in lipid levels and other characteristics
between participants who were followed up to adulthood
and those who withdrew from the study, Student’s t-test
and the chi-square test were used.
The tracking patterns were evaluated using three
methods. First, the tracking pattern was visualized using
several figures that showed the changes in mean values of
baseline quartile groups as age increased. For this purpose,
each lipid profile value at 12 years of age (measurement
year: 1992, n = 343) was divided into four groups accord-
ing to the quartile value of each lipid level to obtain the
maximum tracking time. The mean value of each baseline
group at each follow-up examination is presented as a fig-
ure. Second, we used the Spearman correlation coefficient
(ρ) for lipid profiles between each measurement year from
adolescence to adulthood. The Spearman correlation coef-
ficients are presented according to the measurement time
intervals. Third, we used a tracking coefficient reported by
Twisk [8] because the traditional Spearman correlation
coefficients can only evaluate the correlation between two
measurements. To calculate the tracking coefficients, we
used a generalized estimating equation (GEE) to evaluate
the overall correlation. The formula to calculate the track-
ing coefficient is as follows:
Y it ¼ β0 þ β1Y it1 þ β2t þ
XJ
j¼1
β3jXijt þ εit
In this formula, Yit is the observation for subject i at time
t, Yit1 is the first observation for subject i, Xijt is the jth
covariate for subject i at time t (where the number of total
covariates = J), and εit indicates the error term. Detailed in-
formation on the formula has been published elsewhere [8].
Among the regression coefficients β, the standardized β1 is
the tracking coefficient. To obtain the standardized β1, the
SD of Yit1 was multiplied by β1, and then the SD of Yit was
divided by β1. The correlations between the initial
measurements and all other remaining measurements were
integrated into a single tracking coefficient, β. The tracking
coefficient has competitive strength when unbalanced data
sets are used because it can handle missing values and data
with unequal time intervals. In addition, it allows for the
adjustment of possible confounders, such as age and BMI.
To calculate the tracking coefficient for lipid profiles, we
analyzed 1869 measurements from 432 participants. The
tracking coefficients for men, women, and all participants
were calculated. We analyzed the adjusted tracking coeffi-
cient by adjusting for sex, age, BMI, and SBP at each
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measurement. To solve the problem of multiple compari-
sons, the Bonferroni correction was used. The study partici-
pants took part in up to six measurements, so p values of
<0.008 were considered to be statistically significant for this
comparison. Otherwise, unless noted, p values of <0.05
were considered to be statistically significant. All analyses
were performed using SAS version 9.4 (SAS Institute Inc.,
Cary, NC, USA).
Results
Table 1 shows the general characteristics of the study par-
ticipants at each measurement. The mean ages of partici-
pants were 12 years, 14 years, 16 years, 25 years, 30 years,
and 35 years of age at adolescence 1–3 and adult waves
2–4, respectively. The measurement periods were longer
during adult waves 3 and 4 than in previous waves; there-
fore, the SDs for the participants’ age in adult waves 3 and
4 are larger than those of participants before adult wave 3.
The total cholesterol levels decreased during adolescence
and increased in adulthood. Non-HDL cholesterol and
LDL cholesterol levels showed similar patterns. BMI, SBP,
and DBP tended to increase as age increased.
Figure 1 shows the tracking patterns for the lipid levels of
study participants from ages 12 to 35 years according to the
mean values of the quartile groups at 12 years of age (adoles-
cence 1, n= 342). The >75p group includes the participants
who had higher lipid levels than the 75th percentile value at
12 years of age. The 50–75p group includes the participants
who had lipid levels between the 50th and 75th percentile
values by age. The 25–50p group includes participants who
had lipid levels between the 25th and 50th percentile values
by age. The <25 group includes participants who had lower
lipid levels than the 25th percentile values by age. In the ab-
sence of a tracking pattern, the mean values for each quartile
group would gradually converge. The trends for total choles-
terol, HDL cholesterol, non-HDL cholesterol, and LDL chol-
esterol showed similar sustained differences among each
quartile groups, while the difference of mean values between
the 25th–50th and the 50th–75th percentile groups de-
creased at age 30 years, as shown in Fig. 1. Triglycerides
showed an irregular tracking pattern.
To evaluate the statistical significance of tracking pat-
terns, Spearman correlation coefficients were calculated
(Table 2). All coefficients were significant based on p values
(all p values were <0.05); however, the magnitude of these
values shows a difference. The range of coefficients was
0.38–0.69 for total cholesterol, 0.12–0.66 for triglycerides,
and 0.41–0.69 for HDL cholesterol. The coefficients for
non-HDL cholesterol and LDL cholesterol showed a similar
trend as those of total cholesterol and HDL cholesterol. In
general, as the time interval increased, the magnitude of
coefficients tended to decrease.
Table 3 shows the tracking coefficients, which were 0.58
(95% confidence interval [CI]: 0.54–0.63) for total choles-
terol, 0.39 (0.31–0.48) for triglycerides, and 0.51 (0.47–0.56)
for HDL cholesterol when adjusted for age, sex, BMI, and
SBP at each measurement. The tracking coefficients of
non-HDL cholesterol and LDL cholesterol (which were
calculated from other lipid measurements, such as total
cholesterol, triglycerides, and HDL cholesterol) were not
higher than those of total cholesterol. The tracking
coefficients were consistent in their magnitude before and
after adjustment. In a subgroup analysis by sex, the tracking
coefficients were higher in women than in men, except for
HDL cholesterol. The tracking coefficient of HDL choles-
terol was the highest compared to other coefficients for
men, whereas the tracking coefficient of total cholesterol
was the highest for women.
Table 1 General characteristics of study participants for six measurement periods
Characteristics Adolescence 1 Adolescence 2 Adolescence 3 Adult wave 2 Adult wave 3 Adult wave 4
n 342 346 402 275 262 247
Age, years 12.96 ± 0.29 14.97 ± 0.29 16.96 ± 0.30 25.75 ± 0.32 30.73 ± 0.57 35.91 ± 0.66
Sex (% men) 163 (47.7) 168 (48.6) 188 (46.8) 126 (45.8) 123 (47.0) 136 (55.1)
Total cholesterol, mmol/L 4.19 ± 0.66 4.10 ± 0.70 3.93 ± 0.69 4.24 ± 0.72 4.76 ± 0.87 4.97 ± 0.85
Triglyceride, mmol/L 1.18 ± 0.47 1.21 ± 0.51 1.24 ± 0.68 1.02 ± 0.64 1.17 ± 0.88 1.48 ± 0.99
HDL cholesterol, mmol/L 1.23 ± 0.22 1.15 ± 0.22 1.16 ± 0.25 1.49 ± 0.31 1.30 ± 0.32 1.45 ± 0.36
Non-HDL cholesterol, mmol/L 2.96 ± 0.61 2.95 ± 0.64 2.78 ± 0.65 2.75 ± 0.69 3.46 ± 0.83 3.52 ± 0.89
LDL cholesterol, mmol/La 2.42 ± 0.57 2.39 ± 0.59 2.21 ± 0.62 2.28 ± 0.61 2.93 ± 0.66 2.85 ± 0.77
Body mass index, kg/m2b 18.90 ± 3.08 20.18 ± 2.98 21.03 ± 2.67 21.82 ± 3.01 23.09 ± 3.54 23.65 ± 3.44
Systolic blood pressure, mmHgb 111.57 ± 10.56 116.62 ± 11.53 116.08 ± 11.68 118.60 ± 14.35 116.13 ± 14.22 116.99 ± 13.83
Diastolic blood pressure, mmHgb 65.42 ± 9.39 67.62 ± 9.49 66.56 ± 8.53 69.90 ± 8.43 70.06 ± 9.17 75.70 ± 10.22
Abbreviations: HDL high-density lipoprotein, LDL low-density lipoprotein
Values are expressed as means ± standard deviations or numbers (%). aThe number of participants was somewhat different due to missing values (400 at
adolescence 3, 258 at adult wave 3, and 244 at adult wave 4). bThe number of participants was somewhat different due to missing values (340 at adolescence 1,
345 at adolescence 2, and 400 at adolescence 3)
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Discussion
In this long-term follow-up study of Korean adolescents,
blood lipid levels showed notable tracking patterns. When
compared to the tracking patterns of other lipids, the track-
ing pattern of triglycerides was the weakest. Because there
is no criterion standard for evaluating tracking patterns of
multiple measurements [8], we used several methods in our
study. Traditionally, Pearson and Spearman correlation
coefficients have been used for evaluating the tracking
patterns between two measurements. This study used
Spearman correlation coefficients when we were assessing
the correlation between lipid measurements, because lipids
were not normally distributed in our data. The interpret-
ation of Spearman correlation coefficients between two
measurements is relatively simple; negligible, 0.0–0.3; low
positive, 0.3–0.5; moderate positive, 0.5–0.7; high positive,
0.7–0.9; and very high positive, 0.9–1.0. [20]; however, it
becomes difficult when multiple measurements are in-
volved. Therefore, we calculated the tracking coefficients
using the GEE method [4, 8] to find an integrated value for
multiple lipid measurements for tracking.
We considered the unequal time intervals between mea-
surements, age, sex, SBP, and BMI to be possible con-
founders. We chose BMI and SBP as possible confounders
to evaluate the independent tracking pattern of lipids be-
cause the tracking of obesity was reported to be stronger
than for other CVD risk factors [15]; in addition, a previous
study using the Kangwha Study data showed a noticeable
tracking pattern of SBP from childhood to adulthood [18].
Our results showed consistency in the magnitude of
tracking coefficients before and after the adjustment was
made. This indicates that the effect of confounders on lipid
tracking is not large. Both genetic and environmental fac-
tors can affect blood lipids tracking from adolescence to
Fig. 1 Tracking patterns of lipid levels for study participants from adolescence to adulthood. a Total cholesterol. b Triglycerides. c HDL cholesterol. d
Non-HDL cholesterol. e LDL cholesterol. Each point in the figures represents the mean value of lipid levels in the baseline quartile group (at 12 years of
age, n = 342) at each measurement: at 14 years of age, n = 335; at 16 years of age, n = 313; at 25 years of age, n = 222; at 30 years of age, n = 199; at
35 years of age, n = 186 for total cholesterol. (The number of participants at each measurement for LDL cholesterol was somewhat different due to
missing values)
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Table 2 Spearman correlation coefficients between the lipid levels of study participants according to measurement intervals
Correlation of lipid measurements
by different intervals
n Total cholesterol Triglycerides HDL cholesterol Non-HDL cholesterol LDL cholesterola
23-year correlation (age 12 to 35 years) 186 0.41 0.17 0.43 0.34 0.37
21-year correlation (age 14 to 35 years) 186 0.44 0.27 0.46 0.39 0.35
19-year correlation (age 16 to 35 years) 230 0.46 0.32 0.49 0.42 0.43
18-year correlation (age 12 to 30 years) 199 0.38 0.12 0.41 0.36 0.38
16-year correlation (age 14 to 30 years) 203 0.49 0.33 0.58 0.44 0.45
14-year correlation (age 16 to 30 years) 251 0.48 0.32 0.51 0.44 0.44
13-year correlation (age 12 to 25 years) 222 0.46 0.21 0.45 0.44 0.44
11-year correlation (age 12 to 35 years) 225 0.53 0.28 0.52 0.45 0.45
10-year correlation (age 25 to 35 years) 126 0.61 0.66 0.64 0.69 0.62
9-year correlation (age 16 to 25 years) 259 0.51 0.37 0.54 0.45 0.46
5-year correlation (age 25 to 30 years) 154 0.69 0.57 0.69 0.69 0.64
5-year correlation (age 30 to 35 years) 167 0.63 0.56 0.66 0.68 0.63
4-year correlation (age 12 to 16 years) 313 0.59 0.34 0.58 0.64 0.52
2-year correlation (age 12 to 14 years) 335 0.62 0.39 0.62 0.65 0.58
2-year correlation (age 14 to 16 years) 322 0.69 0.45 0.63 0.73 0.66
Abbreviations: HDL high-density lipoprotein, LDL low-density lipoprotein
All p values of correlation coefficients were <0.05. aThe number of participants for calculating the correlation coefficients of LDL cholesterol was somewhat
different due to missing values
Table 3 Unadjusted and adjusted tracking coefficients of lipid levels for study participants from adolescence to adulthood according to sex
Lipids Number of
participants
Average number of
measurements per person
Tracking coefficient (95% CI)
Unadjusted Adjusteda
Total
Total cholesterol 432 4.33 0.58 (0.54–0.62) 0.58 (0.54–0.63)
Triglyceride 432 4.33 0.40 (0.32–0.49) 0.39 (0.31–0.48)
HDL cholesterol 432 4.33 0.54 (0.49–0.60) 0.51 (0.47–0.56)
Non-HDL cholesterol 432 4.33 0.56 (0.52–0.61) 0.56 (0.52–0.60)
LDL cholesterol 432 4.30 0.57 (0.52–0.61) 0.56 (0.52–0.61)
Men
Total cholesterol 205 4.40 0.52 (0.46–0.58) 0.52 (0.46–0.58)
Triglyceride 205 4.40 0.44 (0.31–0.56) 0.39 (0.26–0.52)
HDL cholesterol 205 4.40 0.58 (0.52–0.64) 0.56 (0.51–0.62)
Non-HDL cholesterol 205 4.40 0.51 (0.45–0.58) 0.50 (0.44–0.56)
LDL cholesterol 205 4.34 0.50 (0.43–0.57) 0.50 (0.43–0.57)
Women
Total cholesterol 227 4.26 0.68 (0.62–0.73) 0.67 (0.61–0.72)
Triglyceride 227 4.26 0.42 (0.36–0.49) 0.41 (0.35–0.48)
HDL cholesterol 227 4.26 0.52 (0.45–0.59) 0.50 (0.43–0.56)
Non-HDL cholesterol 227 4.26 0.69 (0.63–0.74) 0.65 (0.59–0.71)
LDL cholesterol 227 4.26 0.65 (0.59–0.71) 0.63 (0.57–0.69)
Abbreviations: HDL high-density lipoprotein, CI confidence interval
All p values of tracking coefficients were <0.008. aAdjusted for sex, measurement year, body mass index, and systolic blood pressure at each measurement
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adulthood, although it is unclear which factors are more in-
fluential. One twin study in China shows the tracking pat-
terns for total cholesterol, triglyceride, and LDL cholesterol
were predominantly influenced by genetic factor [21]. Our
results might be affected by the genetically determined level
of each individual. However, further longitudinal study
which evaluates the influence on lipid tracking of both gen-
etic and environmental factors is needed as a future work.
The results from the Spearman correlation coefficients
(Table 2) and the tracking coefficients using the GEE
method (Table 3) are consistent in our study. When evalu-
ating the tracking phenomenon of repeatedly measured
values over a long-term period, some values measured at
short intervals can inflate the tracking coefficients of the
entire period. Therefore, time-specific Spearman correl-
ation coefficients and unified tracking coefficients are
required to adequately evaluate long-term tracking coeffi-
cients. Figure 1 shows the overall tracking patterns of lipid
levels for study participants from adolescence to adulthood,
as well as similar tracking patterns to Tables 2 and 3.
A few studies have addressed the tracking of blood lipid
changes from adolescence to adulthood. The Busselton study
[12] showed that the correlation coefficients of cholesterol
for tracking ranged from 0.35 to 0.55; in addition, the coeffi-
cient for a shorter time interval between measurements
tended to show a strong correlation among adolescents at
baseline. The Pune Children’s Study [7] reported 13-year cor-
relation coefficients with a distribution of 0.26–0.53 from
childhood to early adulthood. Our results are consistent with
these previous studies, although our participants had differ-
ent ages and were from a different country. One previous
study [22] reported somewhat different results for lipid track-
ing with respect to sex and ethnicity, but it did not include
Asian adolescents and only had a short follow-up period. A
few studies tracked lipids in children and adolescents in East
Asia [16, 17]. However, no study has been performed in East
Asia to track lipids from adolescence to adulthood. Thus,
our results should contribute to the understanding of long-
term lipid tracking patterns in an East Asian population.
We mainly used tracking coefficients that were calcu-
lated using GEE to determine tracking patterns. We cate-
gorized the coefficients as follows, based on a previous
study: low, ≤0.30; moderate, 0.30–0.59; moderately high,
0.60–0.89; and high, ≥0.9 [5]. Our study shows that signifi-
cant correlation exists among lipid profile measurements,
with tracking coefficients in the 0.39–0.67 range (Table 3).
For women, the tracking coefficients for total cholesterol,
non-HDL cholesterol, and LDL cholesterol showed
moderately high correlation; other tracking coefficients
showed moderate correlation according to the above
criteria. Several studies have used tracking coefficients to
determine tracking patterns. Ulmer et al. [5] reported
tracking coefficients for blood lipids in the range of 0.62–
0.66 for men and 0.63–0.69 for women over 15 years.
Wilsgaard et al. [4] showed tracking coefficients for blood
lipids in the range of 0.43–0.77 for men and 0.39–0.64 for
women over 16 years. Twisk et al. [23] reported tracking
coefficients for serum HDL cholesterol of 0.51 for men
and 0.65 for women during adulthood. Our results for
tracking coefficients were similar with these previously re-
ported results.
In our study, the tracking coefficients for triglycerides
were generally lower than those for other lipid profiles.
The low coefficients for triglycerides might be affected
by inappropriate fasting in the study population during
adolescence examinations. In addition, women showed
higher tracking coefficients than men did in our study,
except for HDL cholesterol. Considering that sexual ma-
turity varies by age, the difference in lipid tracking pat-
terns with respect to sex might be due to the effects of
sex hormones during adolescence [24, 25]. The roles of
non-HDL and LDL cholesterol have been emphasized in
the prediction of CVD, especially for children and ado-
lescents [15, 26]. We calculated non-HDL and LDL
cholesterol and evaluated their tracking patterns; how-
ever, there was no noticeable increase compared to those
of total and HDL cholesterols. Further studies are
needed to evaluate the usefulness of non-HDL and LDL
cholesterol levels at adolescent for predicting CVD.
Lipid screening during adolescence is controversial [15,
27]. In 2011, the US National Heart, Lung, and Blood Insti-
tute recommended that universal lipid screening tests be
conducted twice in adolescence and young adulthood, at
9–11 years and 17–21 years of age [15]. In 2016, the US
Preventive Services Task Force concluded that there was in-
sufficient evidence to recommend lipid screenings for chil-
dren and adolescents [27]. It is difficult to apply such
guidelines directly to Asian countries because there are dis-
parities in lipid levels among different ethnicities [14].
Moreover, long-term follow-up periods have been lacking
in studies of lipid tracking in Asian populations. Thus, fur-
ther epidemiological research is necessary to determine the
benefits of lipid screenings in early periods of life for Asian
populations. Although recent studies showed that adoles-
cent CVD risk factors can predict the future risk of devel-
oping clinical CVD, the usefulness of mass screening at
adolescence may vary depending on the magnitude of long-
term tracking of risk factor levels [28, 29]. In this regard,
our study demonstrated notable tracking patterns for lipids
in Koreans from adolescence to adulthood, which supports
the importance of the early measurement of lipids.
Our study had several strengths. First, to the best
of our knowledge, this study is the first to investigate
the tracking patterns of lipid profiles from adoles-
cence to adulthood in East Asia. The long follow-up
period—more than 23 years—is also a strong point of this
study. Second, the study participants had similar ages and
residences at adolescence; thus, the potential confounding
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effects of age or residence should be minimized. Third, we
used various methods to evaluate tracking patterns and
derived an integrated tracking coefficient. Using these
methods, we were able to account for missing values, re-
flect unequal time intervals, and adjust for other potential
confounders, such as BMI and SBP.
However, there are some limitations to this research.
First, our study participants do not represent the Korean
population as a whole. Thus, we compared our study
participants to the individuals of same age from the Korea
National Health and Nutrition Examination Survey. In the
study, the mean values of total cholesterol level of men
were 4.11 mmol/L for 12–13 years of age, 3.88 for 14–15,
and 3.83 for 16–17, while the mean values of women were
higher than those of men; 4.16 mmol/L for 12–13 years of
age, 4.13 for 14–15, and 4.19 for 16–17, respectively [30].
These lipids levels and trends do not show large difference
compared to our study results. But, the results of our study
should be applied carefully to other populations. Second,
our study had a low follow-up rate. To overcome this
limitation, we conducted comparison analyses for general
characteristics at adolescence 1 between participants who
were followed up to adulthood and those who withdrew be-
fore adulthood. Most characteristics did not show signifi-
cant differences between the groups (See Additional file 1:
Table S1). Third, the lack of lipid profile measurements in
childhood was also another limitation. Further research
which considers the entire human lifespan is needed.
Fourth, the change of devices for lipid measurement is also
a limitation. It can cause measurement error. There are
several studies regarding reliability of lipid measurement,
but results are controversial [31, 32]. Fifth, we could not
analyze genetic or behavioral risk factors which can affect
lipids levels and tracking patterns due to lack of related
data. Finally, we could not obtain reliable information on
any medication that might affect the tracking patterns of
our participants. Generally, lipid-lowering drugs would
stabilize the lipid levels of participants who had abnormal
lipid levels. In this regard, our results might be less affected.
Conclusions
Our study showed a moderately high tracking pattern
for blood lipids from adolescence to adulthood. Triglyc-
erides showed slightly irregular patterns in some age
groups, although other cholesterols (e.g., total, HDL,
non-HDL, LDL) showed consistent patterns in all age
groups. As the time interval increased, the correlations
for lipids decreased; however, all coefficient correlations
were significant. The tracking coefficients were greater
for women than for men, except in the case of HDL
cholesterol. Our results support the usefulness of early
lipid measurements for identifying high-risk individuals
in advance based on the tracking patterns of lipids.
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those who withdrew before adulthood. (DOCX 28 kb)
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